Umene Kenichi, Koga Chihiro, Kameyama Tadamitsu
Department of Nutrition & Health Science, Faculty of Human Environmental Science, Fukuoka Woman's University, Fukuoka 813-8529, Japan.
J Virol Methods. 2007 Feb;139(2):159-65. doi: 10.1016/j.jviromet.2006.09.021. Epub 2006 Oct 30.
The restriction fragment length polymorphism (RFLP) was analyzed using a set of herpes simplex virus type 1 (HSV-1) strains isolated from oro-facial lesions (oro-facial site collection), which was composed of two subsets: one subset consisted of 57 strains from primary oro-facial lesions, and the other of 47 strains from recurrent oro-facial lesions of patients complicated by factors possibly triggering the recurrence (e.g. malignancy, operation, and treatment of dental caries). RFLP analysis was carried out previously on two other sets of HSV-1 strains: one set was from genital lesions (genital site collection), and the other was from non-genital lesions (non-genital site collection). Discriminant analysis was carried out on the three sets of HSV-1 strains: the criterion variable had two values of primary infection or recurrence, and the predictor variables were 20 RFLPs. The degrees of separation between primary infection and recurrence increased in the order oro-facial site collection, genital site collection, and non-genital site collection. The results of discriminant analysis in this study confirmed that reactivation of HSV-1 infection is influenced by triggering factors and the site of infection, thereby suggesting the capabilities of multivariate analysis (including discriminant analysis) with DNA polymorphisms for molecular epidemiological studies.
利用一组从口腔面部病变中分离出的1型单纯疱疹病毒(HSV-1)毒株(口腔面部部位收集样本)分析了限制性片段长度多态性(RFLP),该样本由两个子集组成:一个子集由57株来自原发性口腔面部病变的毒株组成,另一个子集由47株来自伴有可能引发复发因素(如恶性肿瘤、手术和龋齿治疗)的复发性口腔面部病变患者的毒株组成。此前已对另外两组HSV-1毒株进行了RFLP分析:一组来自生殖器病变(生殖器部位收集样本),另一组来自非生殖器病变(非生殖器部位收集样本)。对这三组HSV-1毒株进行了判别分析:标准变量有原发性感染或复发两个值,预测变量为20个RFLP。原发性感染和复发之间的分离程度按口腔面部部位收集样本、生殖器部位收集样本和非生殖器部位收集样本的顺序增加。本研究的判别分析结果证实,HSV-1感染的再激活受触发因素和感染部位的影响,从而表明DNA多态性的多变量分析(包括判别分析)在分子流行病学研究中的能力。